Dna X (SONM) Return on Sales (2018 - 2025)

Dna X's Return on Sales history runs 8 years deep, the most recent figure standing at 0.0% for Q3 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.0% (changed 0.0% YoY) and the FY2024 annual result came in at 0.01%, down 1.0% from the prior year.
• Return on Sales was 0.0% for Q3 2025 at Dna X, up from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2024 and bottomed at 0.01% in Q1 2021.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales grew 1 bps — and 2023, when it fell 1 bps.
• Dna X's Return on Sales stood at 0.01% in 2021, then surged by 172 bps to 0.01% in 2022, then sank by 118 bps to 0.0% in 2023, then soared by 1325 bps to 0.01% in 2024, then tumbled by 125 bps to 0.0% in 2025.
• Business Quant data shows SONM's Return on Sales at 0.0% in Q3 2025, 0.01% in Q2 2025, and 0.0% in Q1 2025.